Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series.
Antibiotic
Cellulitis
Emergency department
Oritavancin
Skin and soft tissue infection
Vancomycin
Journal
The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
11
11
2020
revised:
18
01
2021
accepted:
20
01
2021
pubmed:
6
2
2021
medline:
22
6
2021
entrez:
5
2
2021
Statut:
ppublish
Résumé
Skin and soft tissue infections, such as cellulitis, are commonly diagnosed in the emergency department and these patients are often admitted to the hospital for intravenous antibiotic therapy. Oritavancin is a novel antibiotic approved for the treatment of skin and soft tissue infections that is administered as a one-time infusion. While oritavancin has demonstrated comparable efficacy with multi-dose parenteral antibiotics in clinical trials and has been proposed as an alternative to admission for emergency department patients, there is a paucity of available real world effectiveness data. In this case series, we describe the characteristics and outcomes of ten patients with high-risk skin and soft tissue infections who received oritavancin and were discharged from the emergency department.
Identifiants
pubmed: 33545550
pii: S0735-6757(21)00053-X
doi: 10.1016/j.ajem.2021.01.050
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Lipoglycopeptides
0
oritavancin
PUG62FRZ2E
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
77-80Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.